Treating major depression with yoga: A prospective, randomized, controlled pilot trial

Sudha Prathikanti, Renee Rivera, Ashly Cochran, Jose Gabriel Tungol, Nima Fayazmanesh, Eva Weinmann, Sudha Prathikanti, Renee Rivera, Ashly Cochran, Jose Gabriel Tungol, Nima Fayazmanesh, Eva Weinmann

Abstract

Background: Conventional pharmacotherapies and psychotherapies for major depression are associated with limited adherence to care and relatively low remission rates. Yoga may offer an alternative treatment option, but rigorous studies are few. This randomized controlled trial with blinded outcome assessors examined an 8-week hatha yoga intervention as mono-therapy for mild-to-moderate major depression.

Methods: Investigators recruited 38 adults in San Francisco meeting criteria for major depression of mild-to-moderate severity, per structured psychiatric interview and scores of 14-28 on Beck Depression Inventory-II (BDI). At screening, individuals engaged in psychotherapy, antidepressant pharmacotherapy, herbal or nutraceutical mood therapies, or mind-body practices were excluded. Participants were 68% female, with mean age 43.4 years (SD = 14.8, range = 22-72), and mean BDI score 22.4 (SD = 4.5). Twenty participants were randomized to 90-minute hatha yoga practice groups twice weekly for 8 weeks. Eighteen participants were randomized to 90-minute attention control education groups twice weekly for 8 weeks. Certified yoga instructors delivered both interventions at a university clinic. Primary outcome was depression severity, measured by BDI scores every 2 weeks from baseline to 8 weeks. Secondary outcomes were self-efficacy and self-esteem, measured by scores on the General Self-Efficacy Scale (GSES) and Rosenberg Self-Esteem Scale (RSES) at baseline and at 8 weeks.

Results: In intent-to-treat analysis, yoga participants exhibited significantly greater 8-week decline in BDI scores than controls (p-value = 0.034). In sub-analyses of participants completing final 8-week measures, yoga participants were more likely to achieve remission, defined per final BDI score ≤ 9 (p-value = 0.018). Effect size of yoga in reducing BDI scores was large, per Cohen's d = -0.96 [95%CI, -1.81 to -0.12]. Intervention groups did not differ significantly in 8-week change scores for either the GSES or RSES.

Conclusion: In adults with mild-to-moderate major depression, an 8-week hatha yoga intervention resulted in statistically and clinically significant reductions in depression severity.

Trial registration: ClinicalTrials.gov NCT01210651.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Participant flow diagram.
Fig 1. Participant flow diagram.
Fig 2. Intent-to-treat analysis: Adjusted mean BDI…
Fig 2. Intent-to-treat analysis: Adjusted mean BDI scores plotted by time.

References

    1. Hedden S, Kennet J, Lipari R, Medley G, Tice P, Copello E, et al. Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health [Internet]. Center for Behavioral Health Statistics and Quality. HHS Publications No. SMA 15–4927, NSDUH Series H-50; 2015.
    1. Murray CJL. The State of US Health, 1990–2010: Burden of Diseases, Injuries, and Risk Factors. JAMA. 2013;310: 591 10.1001/jama.2013.13805
    1. Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA, Centers for Disease Control and Prevention (CDC). CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors—United States, 2005–2013. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002. 2014;63 Suppl 4: 3–27.
    1. Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry. 1999;60 Suppl 2: 57–62-76, 113–116.
    1. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66: 802–813. 10.1097/01.psy.0000146332.53619.b2
    1. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33: 203–216. 10.1016/j.genhosppsych.2011.02.007
    1. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations: A Scientific Statement From the American Heart Association. Circulation. 2014;129: 1350–1369. 10.1161/CIR.0000000000000019
    1. Dhar AK, Barton DA. Depression and the Link with Cardiovascular Disease. Front Psychiatry. 2016;7.
    1. Zhang X, N SL, G EW, C YJ, Beckles G, K HS. Depressive Symptoms and Mortality among Persons with and without Diabetes. Am J. 2005;161: 652–660.
    1. Park M, Katon WJ, Wolf FM. Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry. 2013;35: 217–225. 10.1016/j.genhosppsych.2013.01.006
    1. Hofmann M, Köhler B, Leichsenring F, Kruse J. Depression as a Risk Factor for Mortality in Individuals with Diabetes: A Meta-Analysis of Prospective Studies. Al Naggar RA, editor. PLoS ONE. 2013;8: e79809 10.1371/journal.pone.0079809
    1. American Psychiatric Association, American Psychiatric Association, editors. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed Washington, D.C: American Psychiatric Association; 2013.
    1. Bentley SM, Pagalilauan GL, Simpson SA. Major Depression. Med Clin North Am. 2014;98: 981–1005. 10.1016/j.mcna.2014.06.013
    1. González HM, Vega WA, Williams DR, Tarraf W, West BT, Neighbors HW. Depression Care in the United States: Too Little for Too Few. Arch Gen Psychiatry. 2010;67: 37–46. 10.1001/archgenpsychiatry.2009.168
    1. Wierzbicki M, Pekarik G. A meta-analysis of outpatient therapy dropout studies. Prof Psychol Res Pract. 1993;24: 190–195.
    1. Edlund MJ, Wang PS, Berglund PA, Katz SJ, Lin E, Kessler RC. Dropping Out of Mental Health Treatment: Patterns and Predictors Among Epidemiological Survey Respondents in the United States and Ontario. Am J Psychiatry. 2002;159: 845–851. 10.1176/appi.ajp.159.5.845
    1. Masand PS. Tolerability and adherence issues in antidepressant therapy. Clin Ther. 2003;25: 2289–2304.
    1. Mohr DC, Hart SL, Howard I, Julian L, Vella L, Catledge C, et al. Barriers to psychotherapy among depressed and nondepressed primary care patients. Ann Behav Med Publ Soc Behav Med. 2006;32: 254–258.
    1. Arnow BA, Blasey C, Manber R, Constantino MJ, Markowitz JC, Klein DN, et al. Dropouts versus completers among chronically depressed outpatients. J Affect Disord. 2007;97: 197–202. 10.1016/j.jad.2006.06.017
    1. Olfson M, Mojtabai R, Sampson N, Hwang I, Druss B, Wang P, et al. Dropout From Outpatient Mental Health Care in the United States. Psychiatr Serv. 2009;60.
    1. Warden D, Rush AJ, Carmody TJ, Kashner TM, Biggs MM, Crismon ML, et al. Predictors of Attrition During One Year of Depression Treatment: A Roadmap to Personalized Intervention: J Psychiatr Pract. 2009;15: 113–124. 10.1097/01.pra.0000348364.88676.83
    1. Sharf J, Primavera LH, Diener MJ. Dropout and therapeutic alliance: A meta-analysis of adult individual psychotherapy. Psychother Theory Res Pract Train. 2010;47: 637–645.
    1. Simon G, Ludman E. Predictors of Early Dropout From Psychotherapy for Depression in Community Practice. Psychiatr Serv. 2010;61.
    1. Cooper AA, Conklin LR. Dropout from individual psychotherapy for major depression: A meta-analysis of randomized clinical trials. Clin Psychol Rev. 2015;40: 57–65. 10.1016/j.cpr.2015.05.001
    1. Roberson AM, Castro VM, Cagan A, Perlis RH. Antidepressant nonadherence in routine clinical settings determined from discarded blood samples. J Clin Psychiatry. 2015;
    1. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Raue P, Friedman SJ, et al. Perceived Stigma as a Predictor of Treatment Discontinuation in Young and Older Outpatients With Depression. Am J Psychiatry. 2001;158: 479–481. 10.1176/appi.ajp.158.3.479
    1. Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry. 2002;159: 1354–1360. 10.1176/appi.ajp.159.8.1354
    1. Thase ME. Effectiveness of antidepressants: comparative remission rates. J Clin Psychiatry. 2003;64 Suppl 2: 3–7.
    1. Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, et al. STAR*D: revising conventional wisdom. CNS Drugs. 2009;23: 627–647. 10.2165/00023210-200923080-00001
    1. Stewart JG, Harkness KL. Symptom specificity in the acute treatment of Major Depressive Disorder: A re-analysis of the treatment of depression collaborative research program. J Affect Disord. 2012;137: 87–97. 10.1016/j.jad.2011.12.015
    1. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. N Engl J Med. 2008;358: 252–260. 10.1056/NEJMsa065779
    1. Khin NA, Chen Y-F, Yang Y, Yang P, Laughren TP. Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications. J Clin Psychiatry. 2011;72: 464–472. 10.4088/JCP.10m06191
    1. Cuijpers P, Smit F, Bohlmeijer E, Hollon SD, Andersson G. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry. 2010;196: 173–178. 10.1192/bjp.bp.109.066001
    1. Flint J, Cuijpers P, Horder J, Koole SL, Munafò MR. Is there an excess of significant findings in published studies of psychotherapy for depression? Psychol Med. 2015;45: 439–446. 10.1017/S0033291714001421
    1. Driessen E, Hollon SD, Bockting CLH, Cuijpers P, Turner EH. Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials. Lu L, editor. PLOS ONE. 2015;10: e0137864 10.1371/journal.pone.0137864
    1. Bschor T, Kilarski LL. Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults. Expert Rev Neurother. 2016;16: 367–374. 10.1586/14737175.2016.1155985
    1. Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007;164: 739–752. 10.1176/ajp.2007.164.5.739
    1. Huynh NN, McIntyre RS. What Are the Implications of the STAR*D Trial for Primary Care? A Review and Synthesis. Prim Care Companion J Clin Psychiatry. 2008;10: 91–96.
    1. Connolly KR, Thase ME. If at First You Don’t Succeed: A Review of the Evidence for Antidepressant Augmentation, Combination and Switching Strategies. Drugs. 2011;71: 43–64. 10.2165/11587620-000000000-00000
    1. de Sousa RT, Zanetti MV., Brunoni AR., Machado-Vieira R. Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics. Curr Neuropharmacol. 2015;13: 616–635. 10.2174/1570159X13666150630173522
    1. Quitkin FM, McGrath PJ, Stewart JW, Deliyannides D, Taylor BP, Davies CA, et al. Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients. J Clin Psychiatry. 2005;66: 670–676.
    1. Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: treating depression in the real world. Cleve Clin J Med. 2008;75: 57–66.
    1. Israel JA. The Impact of Residual Symptoms in Major Depression. Pharmaceuticals. 2010;3: 2426–2440. 10.3390/ph3082426
    1. Pence BW, O’Donnell JK, Gaynes BN. The Depression Treatment Cascade in Primary Care: A Public Health Perspective. Curr Psychiatry Rep. 2012;14: 328–335. 10.1007/s11920-012-0274-y
    1. Iyengar BKS. Light on yoga: yoga dipika. Rev. [pbk.] ed. New York: Schocken Books; 1979.
    1. Satchidananda, Patañjali. The yoga sūtras of Patañjali. Buckingham, Va: Integral Yoga Publications; 2012.
    1. Svātmārāma S, Vishnudevananda, Brahmananda. Haṭhayogapradīpikā =: Hatha yoga pradipika: the classic guide for the advanced practice of Hatha Yoga (Kundalini Yoga). New York: OM Lotus Pub. Co; 1987.
    1. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Rep. 2015; 1–16.
    1. Cramer H, Ward L, Saper R, Fishbein D, Dobos G, Lauche R. The Safety of Yoga: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Epidemiol. 2015;182: 281–293. 10.1093/aje/kwv071
    1. Fishbein D, Barrett L, Teranishi R, Saper R, Kruger J. Is Yoga Really Dangerous? A Systematic Review of Adverse Events Reported in the Medical Literature. J Altern Complement Med. 2014;20: A21–A21.
    1. Cramer H, Krucoff C, Dobos G. Adverse Events Associated with Yoga: A Systematic Review of Published Case Reports and Case Series. Acott TS, editor. PLoS ONE. 2013;8: e75515 10.1371/journal.pone.0075515
    1. Saper RB, Eisenberg DM, Davis RB, Culpepper L, Phillips RS. Prevalence and patterns of adult yoga use in the United States: results of a national survey. Altern Ther Health Med. 2004;10: 44–49.
    1. Birdee GS, Legedza AT, Saper RB, Bertisch SM, Eisenberg DM, Phillips RS. Characteristics of Yoga Users: Results of a National Survey. J Gen Intern Med. 2008;23: 1653–1658. 10.1007/s11606-008-0735-5
    1. Upchurch DM, Dye CE, Chyu L, Gold EB, Greendale GA. Demographic, Behavioral, and Health Correlates of Complementary and Alternative Medicine and Prayer Use among Midlife Women: 2002. J Womens Health. 2010;19: 23–30.
    1. Holden SC, Gardiner P, Birdee G, Davis RB, Yeh GY. Complementary and Alternative Medicine Use Among Women During Pregnancy and Childbearing Years. Birth. 2015;42: 261–269. 10.1111/birt.12177
    1. Stussman BJ, Black LI, Barnes PM, Clarke TC, Nahin RL. Wellness-related Use of Common Complementary Health Approaches Among Adults: United States, 2012. Natl Health Stat Rep. 2015; 1–12.
    1. Cramer H, Ward L, Steel A, Lauche R, Dobos G, Zhang Y. Prevalence, Patterns, and Predictors of Yoga Use. Am J Prev Med. 2015;
    1. Wolsko PM, Eisenberg DM, Davis RB, Phillips RS. Use of mind-body medical therapies: Results of a national survey. J Gen Intern Med. 2004;19: 43–50. 10.1111/j.1525-1497.2004.21019.x
    1. Bertisch SM, Wee CC, Phillips RS, McCarthy EP. Alternative mind–body therapies used by adults with medical conditions. J Psychosom Res. 2009;66: 511–519. 10.1016/j.jpsychores.2008.12.003
    1. Purohit MP, Wells RE, Zafonte R, Davis RB, Yeh GY, Phillips RS. Neuropsychiatric Symptoms and the Use of Mind-Body Therapies. J Clin Psychiatry. 2013;74: e520–e526. 10.4088/JCP.12m08246
    1. Pilkington K, Kirkwood G, Rampes H, Richardson J. Yoga for depression: The research evidence. J Affect Disord. 2005;89: 13–24. 10.1016/j.jad.2005.08.013
    1. da Silva TL, Ravindran LN, Ravindran AV. Yoga in the treatment of mood and anxiety disorders: A review. Asian J Psychiatry. 2009;2: 6–16.
    1. Cabral P, Meyer HB, Ames D. Effectiveness of yoga therapy as a complementary treatment for major psychiatric disorders: a meta-analysis. Prim Care Companion CNS Disord. 2011;13.
    1. Balasubramaniam M, Telles S, Doraiswamy PM. Yoga on Our Minds: A Systematic Review of Yoga for Neuropsychiatric Disorders. Front Psychiatry. 2012;3: 117 10.3389/fpsyt.2012.00117
    1. Cramer H, Lauche R, Langhorst J, Dobos G. Yoga for depression: a systematic review and meta-analysis. Depress Anxiety. 2013;30: 1068–1083. 10.1002/da.22166
    1. Gong H, Ni C, Shen X, Wu T, Jiang C. Yoga for prenatal depression: a systematic review and meta-analysis. BMC Psychiatry. 2015;15: 14 10.1186/s12888-015-0393-1
    1. Canadian Agency for Drugs and Technologies in Health. Yoga for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Abuse: A Review of the Clinical Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015.
    1. Broota A, Dhir R. Efficacy of two relaxation techniques in depression. J Clin Stud. 1990;
    1. Veale D, Le Fevre K, Pantelis C, de Souza V, Mann A, Sargeant A. Aerobic exercise in the adjunctive treatment of depression: a randomized controlled trial. J R Soc Med. 1992;85: 541–544.
    1. Khumar S, Kaur P, MS K. Effectiveness of Shavasana on depression among university students. Indian J Clin Psych. 1993;
    1. Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, Harish MG, Subbakrishna DK, Vedamurthachar A. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine. J Affect Disord. 2000;57: 255–259.
    1. Rohini V, P RS, Janakiramaiah N, G BN, Vedamurthachar A. A comparative study of full and partial Sudarshan Kriya Yoga in major depressive disorder. NIMHANS J. 2000: 53–57.
    1. Woolery A, Myers H, Sternlieb B, Zeltzer L. A yoga intervention for young adults with elevated symptoms of depression. Altern Ther Health Med. 2004;10: 60–63.
    1. Sharma VK, Das S, Mondal S, Goswampi U, Gandhi A. Effect of Sahaj Yoga on depressive disorders. Indian J Physiol Pharmacol. 2005;49: 462–468.
    1. Vedamurthachar A, Janakiramaiah N, Hegde JM, Shetty TK, Subbakrishna DK, Sureshbabu SV, et al. Antidepressant efficacy and hormonal effects of Sudarshana Kriya Yoga (SKY) in alcohol dependent individuals. J Affect Disord. 2006;94: 249–253. 10.1016/j.jad.2006.04.025
    1. Krishnamurthy MN, Telles S. Assessing depression following two ancient Indian interventions: effects of yoga and ayurveda on older adults in a residential home. J Gerontol Nurs. 2007;33: 17–23.
    1. Oretzky S. The effects of yoga on elevated depressive and somatic symptoms in young adults. Dissertation Abstracts International: Section B: The Sciences and Engineering, 67(9-B), 5458.; 2007.
    1. Butler LD, Waelde LC, Hastings TA, Chen X-H, Symons B, Marshall J, et al. Meditation with yoga, group therapy with hypnosis, and psychoeducation for long-term depressed mood: a randomized pilot trial. J Clin Psychol. 2008;64: 806–820. 10.1002/jclp.20496
    1. Javnbakht M, Hejazi Kenari R, Ghasemi M. Effects of yoga on depression and anxiety of women. Complement Ther Clin Pract. 2009;15: 102–104. 10.1016/j.ctcp.2009.01.003
    1. Shahidi M, Mojtahed A, Modabbernia A, Mojtahed M, Shafiabady A, Delavar A, et al. Laughter yoga versus group exercise program in elderly depressed women: a randomized controlled trial. Int J Geriatr Psychiatry. 2011;26: 322–327. 10.1002/gps.2545
    1. Mitchell J, Field T, Diego M, Bendell D, Newton R, Pelaez M. Yoga Reduces Prenatal Depression Symptoms. Psychology. 2012;3: 782–786.
    1. Lavretsky H, Epel ES, Siddarth P, Nazarian N, Cyr NS, Khalsa DS, et al. A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity. Int J Geriatr Psychiatry. 2013;28: 57–65. 10.1002/gps.3790
    1. Field T, Diego M, Hernandez-Reif M, Medina L, Delgado J, Hernandez A. Yoga and massage therapy reduce prenatal depression and prematurity. J Bodyw Mov Ther. 2012;16: 204–209. 10.1016/j.jbmt.2011.08.002
    1. Field T, Diego M, Delgado J, Medina L. Tai chi/yoga reduces prenatal depression, anxiety and sleep disturbances. Complement Ther Clin Pract. 2013;19: 6–10. 10.1016/j.ctcp.2012.10.001
    1. Field T, Diego M, Delgado J, Medina L. Yoga and social support reduce prenatal depression, anxiety and cortisol. J Bodyw Mov Ther. 2013;17: 397–403. 10.1016/j.jbmt.2013.03.010
    1. Satyapriya M, Nagarathna R, Padmalatha V, Nagendra HR. Effect of integrated yoga on anxiety, depression & well being in normal pregnancy. Complement Ther Clin Pract. 2013;19: 230–236. 10.1016/j.ctcp.2013.06.003
    1. Kinser PA, Bourguignon C, Whaley D, Hauenstein E, Taylor AG. Feasibility, acceptability, and effects of gentle Hatha yoga for women with major depression: findings from a randomized controlled mixed-methods study. Arch Psychiatr Nurs. 2013;27: 137–147. 10.1016/j.apnu.2013.01.003
    1. Newham JJ, Wittkowski A, Hurley J, Aplin JD, Westwood M. Effects of antenatal yoga on maternal anxiety and depression: a randomized controlled trial. Depress Anxiety. 2014;31: 631–640. 10.1002/da.22268
    1. Kinser PA, Elswick RK, Kornstein S. Potential long-term effects of a mind-body intervention for women with major depressive disorder: sustained mental health improvements with a pilot yoga intervention. Arch Psychiatr Nurs. 2014;28: 377–383. 10.1016/j.apnu.2014.08.014
    1. Sarubin N, Nothdurfter C, Schüle C, Lieb M, Uhr M, Born C, et al. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial. J Psychiatr Res. 2014;53: 76–83. 10.1016/j.jpsychires.2014.02.022
    1. Buttner MM, Brock RL, O’Hara MW, Stuart S. Efficacy of yoga for depressed postpartum women: A randomized controlled trial. Complement Ther Clin Pract. 2015;21: 94–100. 10.1016/j.ctcp.2015.03.003
    1. Davis K, Goodman SH, Leiferman J, Taylor M, Dimidjian S. A randomized controlled trial of yoga for pregnant women with symptoms of depression and anxiety. Complement Ther Clin Pract. 2015;21: 166–172. 10.1016/j.ctcp.2015.06.005
    1. Uebelacker LA, Battle CL, Sutton KA, Magee SR, Miller IW. A pilot randomized controlled trial comparing prenatal yoga to perinatal health education for antenatal depression. Arch Womens Ment Health. 2015;
    1. Khan A, Leventhal RM, Khan SR, Brown WA. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol. 2002;22: 40–45.
    1. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration. Hay P, editor. PLoS Med. 2008;5: e45 10.1371/journal.pmed.0050045
    1. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis. JAMA. 2010;303: 47–53. 10.1001/jama.2009.1943
    1. De Maat S, Dekker J, Schoevers R, De Jonghe F. Relative efficacy of psychotherapy and pharmacotherapy in the treatment of depression: A meta-analysis. Psychother Res. 2006;16: 566–578.
    1. Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, et al. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ. 2015; h6019 10.1136/bmj.h6019
    1. Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. Psychol Rev. 1977;84: 191–215.
    1. Beck AT. Cognitive therapy. A 30-year retrospective. Am Psychol. 1991;46: 368–375.
    1. Bandura A. Health promotion from the perspective of social cognitive theory. Psychol Health. 1998;13: 623–649.
    1. Kovačič T, Kovačič M. Impact of Relaxation Training According to Yoga in Daily Life ® System on Self-Esteem After Breast Cancer Surgery. J Altern Complement Med. 2011;17: 1157–1164. 10.1089/acm.2010.0653
    1. Scult M, Haime V, Jacquart J, Takahashi J, Moscowitz B, Webster A, et al. A healthy aging program for older adults: effects on self-efficacy and morale. Adv Mind Body Med. 2015;29: 26–33.
    1. Sethi JK, Nagendra HR, Sham Ganpat T. Yoga improves attention and self-esteem in underprivileged girl student. J Educ Health Promot. 2013;2: 55 10.4103/2277-9531.119043
    1. Telles S, Singh N, Bhardwaj A, Kumar A, Balkrishna A. Effect of yoga or physical exercise on physical, cognitive and emotional measures in children: a randomized controlled trial. Child Adolesc Psychiatry Ment Health. 2013;7: 37 10.1186/1753-2000-7-37
    1. Das M, Deepeshwar S, Subramanya P, Manjunath NK. Influence of Yoga-Based Personality Development Program on Psychomotor Performance and Self-efficacy in School Children. Front Pediatr. 2016;4: 62 10.3389/fped.2016.00062
    1. Deshpande S, Nagendra HR, Nagarathna R. A randomized control trial of the effect of yoga on Gunas (personality) and Self esteem in normal healthy volunteers. Int J Yoga. 2009;2: 13–21. 10.4103/0973-6131.43287
    1. Waelde LC, Thompson L, Gallagher-Thompson D. A pilot study of a yoga and meditation intervention for dementia caregiver stress. J Clin Psychol. 2004;60: 677–687. 10.1002/jclp.10259
    1. Lee SW, Mancuso CA, Charlson ME. Prospective study of new participants in a community-based mind-body training program. J Gen Intern Med. 2004;19: 760–765. 10.1111/j.1525-1497.2004.30011.x
    1. Bonura KB, Tenenbaum G. of Yoga on Psychological Health in Older AdultsEffects. J Phys Act Health. 2014;11: 1334–1341. 10.1123/jpah.2012-0365
    1. Taspinar B, Aslan UB, Agbuga B, Taspinar F. A comparison of the effects of hatha yoga and resistance exercise on mental health and well-being in sedentary adults: A pilot study. Complement Ther Med. 2014;22: 433–440. 10.1016/j.ctim.2014.03.007
    1. Ferreira-Vorkapic C, Feitoza JM, Marchioro M, Simões J, Kozasa E, Telles S. Are There Benefits from Teaching Yoga at Schools? A Systematic Review of Randomized Control Trials of Yoga-Based Interventions. Evid Based Complement Alternat Med. 2015;2015: 1–17.
    1. Anderzén-Carlsson A, Persson Lundholm U, Köhn M, Westerdahl E. Medical yoga: another way of being in the world-a phenomenological study from the perspective of persons suffering from stress-related symptoms. Int J Qual Stud Health Well-Being. 2014;9: 23033 10.3402/qhw.v9.23033
    1. World Health Organization. Handbook for good clinical research practice (GCP): guidance for implementation. Geneva, Switzerland: World Health Organization; 2005.
    1. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148: 295–309.
    1. Nagarathna R, Nagendra HR. Yoga for anxiety and depression. Bangalore: Swami Vivekananda Yoga Prakashana; 2001.
    1. Fernandes R, Prathikanti S. Treating Depression with Yoga Breathing: An Open-label Feasibility Study. San Diego, CA: Poster presented at the National Institute of Mental Health Summer Training On Aging Research Topics In Mental Health; 2005 Aug.
    1. Kinser PA, Robins JL. Control Group Design: Enhancing Rigor in Research of Mind-Body Therapies for Depression. Evid Based Complement Alternat Med. 2013;2013: 1–10.
    1. Jain FA, Walsh RN, Eisendrath SJ, Christensen S, Rael Cahn B. Critical Analysis of the Efficacy of Meditation Therapies for Acute and Subacute Phase Treatment of Depressive Disorders: A Systematic Review. Psychosomatics. 2015;56: 140–152. 10.1016/j.psym.2014.10.007
    1. MacCoon DG, Imel ZE, Rosenkranz MA, Sheftel JG, Weng HY, Sullivan JC, et al. The validation of an active control intervention for Mindfulness Based Stress Reduction (MBSR). Behav Res Ther. 2012;50: 3–12. 10.1016/j.brat.2011.10.011
    1. Strauss C, Cavanagh K, Oliver A, Pettman D. Mindfulness-Based Interventions for People Diagnosed with a Current Episode of an Anxiety or Depressive Disorder: A Meta-Analysis of Randomised Controlled Trials. Laks J, editor. PLoS ONE. 2014;9: e96110 10.1371/journal.pone.0096110
    1. Ekkekakis P. Honey, I shrunk the pooled SMD! Guide to critical appraisal of systematic reviews and meta-analyses using the Cochrane review on exercise for depression as example. Ment Health Phys Act. 2015;8: 21–36.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20: 22–33-57.
    1. Sheehan DV, Sheehan KH, Shytle RD, Janavs J, Bannon Y, Rogers JE, et al. Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). J Clin Psychiatry. 2010;71: 313–326. 10.4088/JCP.09m05305whi
    1. American Psychiatric Association, American Psychiatric Association, editors. Diagnostic and statistical manual of mental disorders: DSM-4. 4th ed Washington, D.C: American Psychiatric Association; 1994.
    1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12: 189–198.
    1. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269: 2386–2391.
    1. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67: 588–597. 10.1207/s15327752jpa6703_13
    1. Steer RA, Brown GK, Beck AT, Sanderson WC. Mean Beck Depression Inventory-II scores by severity of major depressive episode. Psychol Rep. 2001;88: 1075–1076. 10.2466/pr0.2001.88.3c.1075
    1. Wang Y-P, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Rev Bras Psiquiatr São Paulo Braz 1999. 2013;35: 416–431.
    1. Schwarzer R, Jerusalem M. Generalized Self-Efficacy scale: Causal and control beliefs In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: A user’s portfolio. Windsor, UK: NFER-NELSON; 1995. pp. 35–37.
    1. Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. J Psychol. 2005;139: 439–457. 10.3200/JRLP.139.5.439-457
    1. Rosenberg M. Society and the adolescent self-image. Princeton, NJ: Princeton Univ. Press; 1965.
    1. Sinclair SJ, Blais MA, Gansler DA, Sandberg E, Bistis K, LoCicero A. Psychometric properties of the Rosenberg Self-Esteem Scale: overall and across demographic groups living within the United States. Eval Health Prof. 2010;33: 56–80. 10.1177/0163278709356187
    1. Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH. Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial. JAMA Intern Med. 2015;175: 1773 10.1001/jamainternmed.2015.5220
    1. Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess. 2014;18.
    1. Reeves GM, Rohan KJ, Langenberg P, Snitker S, Postolache TT. Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes. J Affect Disord. 2012;138: 123–127. 10.1016/j.jad.2011.12.003
    1. Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4: Pg 3, Formula 1.
    1. Cohen J. A power primer. Psychol Bull. 1992;112: 155–159.
    1. Celada P, Puig M, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci JPN. 2004;29: 252–265.
    1. Gelenberg Alan, Freeman, M.D. Marlene P., Markowitz, M.D. John C., Rosenbaum, M.D. Jerrold F., Thase, M.D. Michael E., Trivedi, M.D. Madhukar H., et al. PRACTICE GUIDELINE for the Treatment of Patients With Major Depressive Disorder Third Edition [Internet]. 2010.
    1. Uher R, Mors O, Rietschel M, Rajewska-Rager A, Petrovic A, Zobel A, et al. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. J Clin Psychiatry. 2011;72: 1478–1484. 10.4088/JCP.10m06419
    1. Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: From monoamines to glutamate. Exp Clin Psychopharmacol. 2015;23: 1–21. 10.1037/a0038550
    1. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005;28: 1–8.
    1. Rethorst CD, Wipfli BM, Landers DM. The Antidepressive Effects of Exercise: A Meta-Analysis of Randomized Trials. Sports Med. 2009;39: 491–511. 10.2165/00007256-200939060-00004
    1. Mota-Pereira J, Silverio J, Carvalho S, Ribeiro JC, Fonte D, Ramos J. Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder. J Psychiatr Res. 2011;45: 1005–1011. 10.1016/j.jpsychires.2011.02.005
    1. Rethorst CD, Trivedi MH. Evidence-Based Recommendations for the Prescription of Exercise for Major Depressive Disorder: J Psychiatr Pract. 2013;19: 204–212. 10.1097/01.pra.0000430504.16952.3e
    1. Brown RP, Gerbarg PL. Sudarshan Kriya yogic breathing in the treatment of stress, anxiety, and depression: part I-neurophysiologic model. J Altern Complement Med N Y N. 2005;11: 189–201.
    1. Ross A, Thomas S. The Health Benefits of Yoga and Exercise: A Review of Comparison Studies. J Altern Complement Med. 2010;16: 3–12. 10.1089/acm.2009.0044
    1. Uebelacker LA, Epstein-Lubow G, Gaudiano BA, Tremont G, Battle CL, Miller IW. Hatha yoga for depression: critical review of the evidence for efficacy, plausible mechanisms of action, and directions for future research. J Psychiatr Pract. 2010;16: 22–33. 10.1097/01.pra.0000367775.88388.96
    1. Streeter CC, Gerbarg PL, Saper RB, Ciraulo DA, Brown RP. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses. 2012;78: 571–579. 10.1016/j.mehy.2012.01.021
    1. Kinser PA, Goehler LE, Taylor AG. How might yoga help depression? A neurobiological perspective. Explore N Y N. 2012;8: 118–126.
    1. Pascoe MC, Bauer IE. A systematic review of randomised control trials on the effects of yoga on stress measures and mood. J Psychiatr Res. 2015;68: 270–282. 10.1016/j.jpsychires.2015.07.013
    1. Epel E, Daubenmier J, Moskowitz JT, Folkman S, Blackburn E. Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres. Ann N Y Acad Sci. 2009;1172: 34–53. 10.1111/j.1749-6632.2009.04414.x
    1. Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, et al. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology. 2011;36: 664–681. 10.1016/j.psyneuen.2010.09.010
    1. Schuver KJ, Lewis BA. Mindfulness-based yoga intervention for women with depression. Complement Ther Med. 2016;26: 85–91. 10.1016/j.ctim.2016.03.003
    1. Jain S, Shapiro SL, Swanick S, Roesch SC, Mills PJ, Bell I, et al. A randomized controlled trial of mindfulness meditation versus relaxation training: effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med Publ Soc Behav Med. 2007;33: 11–21.
    1. Kingston T, Dooley B, Bates A, Lawlor E, Malone K. Mindfulness-based cognitive therapy for residual depressive symptoms. Psychol Psychother. 2007;80: 193–203. 10.1348/147608306X116016
    1. van Aalderen JR, Donders ART, Giommi F, Spinhoven P, Barendregt HP, Speckens AEM. The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial. Psychol Med. 2012;42: 989–1001. 10.1017/S0033291711002054
    1. Dimidjian S, Barrera M, Martell C, Muñoz RF, Lewinsohn PM. The Origins and Current Status of Behavioral Activation Treatments for Depression. Annu Rev Clin Psychol. 2011;7: 1–38. 10.1146/annurev-clinpsy-032210-104535
    1. Moradveisi L, Huibers MJH, Renner F, Arasteh M, Arntz A. Behavioural activation v. antidepressant medication for treating depression in Iran: randomised trial. Br J Psychiatry. 2013;202: 204–211. 10.1192/bjp.bp.112.113696
    1. Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. Behavioural Activation for Depression; An Update of Meta-Analysis of Effectiveness and Sub Group Analysis. Aleman A, editor. PLoS ONE. 2014;9: e100100 10.1371/journal.pone.0100100
    1. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14: 365–376. 10.1038/nrn3475
    1. Torous J, Staples P, Shanahan M, Lin C, Peck P, Keshavan M, et al. Utilizing a Personal Smartphone Custom App to Assess the Patient Health Questionnaire-9 (PHQ-9) Depressive Symptoms in Patients With Major Depressive Disorder. JMIR Ment Health. 2015;2: e8 10.2196/mental.3889
    1. Ramsey AT, Wetherell JL, Depp C, Dixon D, Lenze E. Feasibility and Acceptability of Smartphone Assessment in Older Adults with Cognitive and Emotional Difficulties. J Technol Hum Serv. 2016;34: 209–223. 10.1080/15228835.2016.1170649
    1. Wichers M, Simons CJP, Kramer IMA, Hartmann JA, Lothmann C, Myin-Germeys I, et al. Momentary assessment technology as a tool to help patients with depression help themselves: ESM and clinical applications in depression. Acta Psychiatr Scand. 2011;124: 262–272. 10.1111/j.1600-0447.2011.01749.x
    1. aan het Rot M, Hogenelst K, Schoevers RA. Mood disorders in everyday life: A systematic review of experience sampling and ecological momentary assessment studies. Clin Psychol Rev. 2012;32: 510–523. 10.1016/j.cpr.2012.05.007
    1. Marcano Belisario JS, Jamsek J, Huckvale K, O’Donoghue J, Morrison CP, Car J. Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2015.
    1. Bos FM, Schoevers RA, aan het Rot M. Experience sampling and ecological momentary assessment studies in psychopharmacology: A systematic review. Eur Neuropsychopharmacol. 2015;25: 1853–1864. 10.1016/j.euroneuro.2015.08.008
    1. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34: 73–82.
    1. Dunlop BW, Binder EB, Cubells JF, Goodman MM, Kelley ME, Kinkead B, et al. Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials. 2012;13: 106 10.1186/1745-6215-13-106
    1. Phillips ML, Chase HW, Sheline YI, Etkin A, Almeida JRC, Deckersbach T, et al. Identifying Predictors, Moderators, and Mediators of Antidepressant Response in Major Depressive Disorder: Neuroimaging Approaches. Am J Psychiatry. 2015;172: 124–138. 10.1176/appi.ajp.2014.14010076
    1. McGrath CL, Kelley ME, Holtzheimer PE, Dunlop BW, Craighead WE, Franco AR, et al. Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder. JAMA Psychiatry. 2013;70: 821 10.1001/jamapsychiatry.2013.143
    1. McGrath CL, Kelley ME, Dunlop BW, Holtzheimer PE III, Craighead WE, Mayberg HS. Pretreatment Brain States Identify Likely Nonresponse to Standard Treatments for Depression. Biol Psychiatry. 2014;76: 527–535. 10.1016/j.biopsych.2013.12.005
    1. Lin P, Campbell DG, Chaney EF, Liu C-F, Heagerty P, Felker BL, et al. The influence of patient preference on depression treatment in primary care. Ann Behav Med Publ Soc Behav Med. 2005;30: 164–173.
    1. Swift JK, Callahan JL, Vollmer BM. Preferences. J Clin Psychol. 2011;67: 155–165. 10.1002/jclp.20759
    1. Rutherford BR, Wager TD, Roose SP. Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome. Curr Psychiatry Rev. 2010;6: 1–10. 10.2174/157340010790596571
    1. Moradveisi L, Huibers M, Renner F, Arntz A. The influence of patients’ preference/attitude towards psychotherapy and antidepressant medication on the treatment of major depressive disorder. J Behav Ther Exp Psychiatry. 2014;45: 170–177. 10.1016/j.jbtep.2013.10.003

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅